ATLANTA, GA--(Marketwire - October 23, 2007) - AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today announced that it will release its third quarter 2007 financial results on Thursday, October 25, 2007, before the U.S. financial markets open.
